AC Immune’s anti-inflammatory drug posts early-stage win
Keyword: Pharmacokinetics
AC Immune's anti-inflammatory therapy has netted a Phase I, first-in-human win in healthy volunteers, setting a positive precedent as the Swiss biopharma company begins dosing patients.In the early-s… [+132 chars]
Read Full Story ↗
Related Content
-
Related Story BioMarin acquiring Alesta Therapeutics for $275 million
-
Related Story Annexon Q2 Earnings Call Highlights
SaaS Metrics